- Location
Bausch Lomb
"-
INSV Has Reported The US District Court Upheld All Four of The Patents Protecting AzaSite
Oct 10, 2013InSite Vision Incorporated (INSV) has reported that the US District Court for the District of New Jersey upheld all four of the patents protecting AzaSite, an azithromycin 1% ophthalmic solution, in a patent infringement lawsuit against ...
-
Bausch+Lomb Technolas Obtained CE Mark for Technolas Teneo 317 Excimer Laser Workstation
Oct 9, 2013Bausch + Lomb Technolas, a US-based eye care company, has obtained the CE mark for its Technolas Teneo 317 excimer laser workstation, which is designed to treat all types of ametropia (refractive errors). In addition to traditional LASIK ...
-
FDA Clearance for New Monthly Disposable Contact Lens Is Obtained by Bausch + Lomb
Oct 8, 2013Bausch + Lomb, a subsidiary of Valeant Pharmaceuticals International, has obtained marketing clearance from the US Food and Drug Administration (FDA) for its newest frequent replacement silicone hydrogel contact lenses made with ...
Tags: Contact Lens, Medicine
-
Valeant Pharmaceuticals Closed The Acquisition of Bausch + Lomb Holdings for $8.7bn
Aug 12, 2013Valeant Pharmaceuticals International has closed the acquisition of Bausch + Lomb Holdings, a US-based manufacturer of eye health products, for $8.7bn. Bausch + Lomb Holdings has a broad portfolio of eye health products, including OTC ...
Tags: Valeant Pharmaceuticals
-
Valeant Agrees to Acquire Contact Lenses Developer Bausch + Lomb Holdings for $8.7bn
May 29, 2013Dermatology products developer Valeant Pharmaceuticals International has entered into a definitive agreement to acquire contact lenses developer Bausch + Lomb Holdings for a cash consideration of $8.7bn, as part of its strategy to enhance ...
-
Bausch + Lomb and Technolas Have Received Clearance for Victus Femtosecond Laser
Dec 18, 2012Bausch + Lomb and Technolas Perfect Vision have received 510(k) clearance from the US Food and Drug Administration (FDA)for Victus Femtosecond Laser platform, designed for use during cataract and corneal surgical procedures. The CE-marked ...
Tags: FDA, Victus platform, surgical procedures, platform
-
Bausch + Lomb Introduces Daily Disposable Contact Lens, Biotrue ONEday
Dec 17, 2012Bausch + Lomb, a provider of ophthalmic surgical devices and instruments, has introduced daily disposable contact lens, Biotrue ONEday. Bausch + Lomb global vision care president Sheila Hopkins said Biotrue ONEday lenses feature a new ...
Tags: Bausch+Lomb, ophthalmic surgical device, daily disposable contact lens
-
FDA Cleared Bausch + Lomb's Envista Glistening-Free IOL
Dec 5, 2012The US Food and Drug Administration (FDA) has cleared Bausch + Lomb's enVista glistening-free, single-piece hydrophobic acrylic Intraocular Lens (IOL). enVista lens, developed by Advanced Vision Science (AVS), is designed to provide ...
Tags: FDA, Bausch+Lomb's, enVista lens
-
Nicox Has Announced The US Launch of Its Rapid Point-of-Care Diagnostic Test
Oct 23, 2012Nicox has announced the US launch of its rapid point-of-care diagnostic test, designed for the detection of acute conjunctivitis. The FDA-cleared and CLIA-waived assay, AdenoPlus, uses its four-step process to detect adenovirus and ...
Tags: rapid point-of-care diagnostic test, FDA, medical devices
-
Lensar Cataract Procedures Carried out in US 26 Sep 2012
Sep 26, 2012LensAR cataract procedures carried out in US 26 Sep 2012 The country's first commercial procedures using the LensAR femtosecond platform have taken place in two locations. The LensAR Laser System LensAR,the Florida-based vendor of ...
Tags: LensAR, LenSx, OptiMedica, Technolas PV, Laser System, Cataract